ENVVENO MEDICAL DL-00001
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in … Read more
Market Cap & Net Worth: ENVVENO MEDICAL DL-00001 (5HJ)
ENVVENO MEDICAL DL-00001 (F:5HJ) has a market capitalization of $217.89 Million (€212.27 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #30798 globally and #3421 in its home market, demonstrating a 3376.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENVVENO MEDICAL DL-00001's stock price €10.50 by its total outstanding shares 20216176 (20.22 Million).
ENVVENO MEDICAL DL-00001 Market Cap History: 2020 to 2026
ENVVENO MEDICAL DL-00001's market capitalization history from 2020 to 2026. Data shows growth from $132.68 Million to $217.89 Million (7.67% CAGR).
ENVVENO MEDICAL DL-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENVVENO MEDICAL DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5HJ by Market Capitalization
Companies near ENVVENO MEDICAL DL-00001 in the global market cap rankings as of March 19, 2026.
Key companies related to ENVVENO MEDICAL DL-00001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ENVVENO MEDICAL DL-00001 Historical Marketcap From 2020 to 2026
Between 2020 and today, ENVVENO MEDICAL DL-00001's market cap moved from $132.68 Million to $ 217.89 Million, with a yearly change of 7.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €217.89 Million | +3704.35% |
| 2025 | €5.73 Million | -90.61% |
| 2024 | €61.01 Million | -37.71% |
| 2023 | €97.95 Million | +3.51% |
| 2022 | €94.63 Million | -19.29% |
| 2021 | €117.25 Million | -11.64% |
| 2020 | €132.68 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ENVVENO MEDICAL DL-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $217.89 Million USD |
| MoneyControl | $217.89 Million USD |
| MarketWatch | $217.89 Million USD |
| marketcap.company | $217.89 Million USD |
| Reuters | $217.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.